Cox headshotPrincipal Investigator: Dr. Zachary Cox

Disease: Heart failure

Research Description: Approximately 90% of heart failure admissions result from too much fluid in the blood. Loop diuretics are often used to treat this condition. However, some patients develop a resistance to loop diuretics, resulting in a recurrence of symptoms. Yet despite this frequent resistance, current international guidelines provide no clear guidance on the best method to restore diuretic efficacy. While the combination of loop diuretics with oral thiazides is the common practice, the current data on this treatment is limited. Off-label use of other diuretics, such as intravenous chlorothiazide or tolvaptan, in combination with loop diuretics might lead to better outcomes with less adverse events. This proof of concept clinical trial will compare the efficacy and safety of new diuretic combination therapies to overcome loop diuretic resistance in patients with heart failure.

CWR funding role: Participating funder

CWR Start date: 2016

Sign up for our eNewsletter today!


First Name

Cures Within Reach


All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes.  CWR is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Tuesday the 20th. Copyright 2018 Cures Within Reach.